You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 43386-0280


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 43386-0280

Drug NameNDCPrice/Unit ($)UnitDate
DIAZEPAM 10 MG RECTAL GEL SYRG 43386-0280-03 258.57757 EACH 2025-04-23
DIAZEPAM 10 MG RECTAL GEL (2PK) 43386-0280-01 258.57757 EACH 2025-04-23
DIAZEPAM 10 MG RECTAL GEL SYRG 43386-0280-02 258.57757 EACH 2025-04-23
DIAZEPAM 10 MG RECTAL GEL SYRG 43386-0280-03 254.60842 EACH 2025-03-19
DIAZEPAM 10 MG RECTAL GEL (2PK) 43386-0280-01 254.60842 EACH 2025-03-19
DIAZEPAM 10 MG RECTAL GEL SYRG 43386-0280-02 254.60842 EACH 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 6 of 6 entries

Best Wholesale Price for NDC 43386-0280

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 43386-0280

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a drug identified by the NDC 43386-0280, it is crucial to first understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product. It consists of a labeler code, a product code, and a package code, each assigned by different entities[1].

Drug Identification and Listing

The NDC 43386-0280 would be associated with a specific labeler, product, and package size. For instance, the labeler code '43386' identifies the manufacturer or distributor, while the product and package codes specify the drug's formulation and packaging, respectively[1].

Market Context of Prescription Drugs

The pharmaceutical market, particularly for prescription drugs, is complex and influenced by various factors.

Global Pricing Trends

Prescription drug prices in the U.S. are significantly higher compared to other countries. Research indicates that U.S. prices are 2.78 times higher than those in 33 other countries and 5.5 times higher than in OECD countries (excluding the U.S.)[4].

Price Increases and Volatility

Recent data shows substantial price increases in the pharmaceutical industry. For example, in 2022, the largest price increase reported was a 2,527% increase for a generic naproxen product. This volatility is a common feature in the generic drug market, where prices can fluctuate significantly[2].

Industry Outlook for 2024

Revenue Growth and Price Erosion

The pharmaceutical industry, especially the generic drug sector, is expected to experience mid-single-digit percent annual price erosion in 2024. However, this is anticipated to be offset by modest revenue growth, marking an improvement from recent trends. Biosimilars are also expected to see substantial revenue growth, though intense competition may impact profitability[3].

Risks and Challenges

The industry faces several risks, including price-fixing litigation and potential increases in FDA inspections of foreign manufacturing facilities. These factors can influence market stability and pricing strategies[3].

Specific Drug Market Analysis

Generic vs. Brand Name Drugs

The drug associated with NDC 43386-0280, if it is a generic product, would likely be subject to the market dynamics of the generic drug industry. This includes the expectation of price erosion but also the potential for revenue growth due to increased demand and market penetration.

Price Transparency and Regulation

Price transparency reports highlight the variability in information provided by manufacturers, which can affect the accuracy of price analyses. Regulatory efforts, such as those requiring price transparency, can impact how drug prices are set and reported[2].

Price Projections

Given the current market trends:

Short-Term Projections

  • Price Erosion: For generic drugs, a mid-single-digit percent annual price erosion is expected. This could mean a reduction in the price of the drug associated with NDC 43386-0280 by around 5-7% in the short term.
  • Revenue Growth: Despite price erosion, modest revenue growth is anticipated due to increased sales volumes and market expansion.

Long-Term Projections

  • Market Stability: The pharmaceutical industry's credit outlook is stable, suggesting that while there may be fluctuations, the overall market is expected to remain stable.
  • Competition and Innovation: The impact of biosimilars and new drug approvals could influence the pricing strategy for existing drugs, potentially leading to further price adjustments to remain competitive.

Key Takeaways

  • NDC Significance: The NDC is crucial for identifying and tracking drug products.
  • Global Pricing Disparities: U.S. prescription drug prices are significantly higher than in other countries.
  • Market Volatility: Generic drug prices can experience substantial increases or decreases.
  • Industry Outlook: Modest revenue growth and price erosion are expected in the generic drug sector.
  • Regulatory Impact: Price transparency and regulatory actions can influence drug pricing.

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, three-segment number that identifies a drug product, including the labeler, product, and package size.

Q: Why are prescription drug prices in the U.S. so high compared to other countries? A: Prescription drug prices in the U.S. are influenced by various factors, including market dynamics, regulatory environments, and the drug mix, leading to higher prices compared to other countries.

Q: What are the expected trends in the generic drug industry for 2024? A: The generic drug industry is expected to experience mid-single-digit percent annual price erosion but also modest revenue growth.

Q: How do regulatory actions impact drug pricing? A: Regulatory actions, such as price transparency requirements and FDA inspections, can influence how drug prices are set and reported, affecting market stability.

Q: What are the potential risks for the pharmaceutical industry in 2024? A: The industry faces risks including price-fixing litigation and increased FDA inspections of foreign manufacturing facilities.

Sources

  1. FDA, "National Drug Code Database Background Information - FDA"
  2. Oregon Department of Consumer and Business Services, "Prescription Drug Price Transparency Results and Recommendations"
  3. S&P Global, "Pharmaceutical Industry 2024 Credit Outlook Is Stable As Revenue Growth Mitigates Pressures"
  4. ASPE, "International Market Size and Prices"

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.